Loading viewer...
investor_presentation
Format: PDF investor_presentation
Teva Pharmaceutical Industries' preliminary financial outlook and guidance for 2016-2019, presented July 2016. The presentation outlines management expectations including the impact of the pending Allergan generics acquisition and operational strategy through 2019.
investor_presentation
29 Pages
investor_presentation
11 Pages
Varian Medical Systems, Inc.
Balaxi Pharmaceuticals Investor Presentation
investor_presentationinvestor_presentation
21 Pages
Balaxi Pharmaceuticals Limited